To offer medical expense loans of up to Rs. 10 lacs for all elective treatments on free EMI under their CareNow PayLater proposition, Fibe (previously EarlySalary), one of India's top consumer lending platforms, has partnered with Pristyn Care...
The AB-rated generic version of the trademarked product Combigan, Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution, 0.2%/0.5%, was just released, according to Upsher-Smith Laboratories, LLC (Upsher-Smith). A collaborative cooperation...
Henry Ford Health, a not-for-profit healthcare organisation in the Detroit metro region, and Illumina Inc., a world leader in DNA sequencing and array-based technologies, have announced the beginning of a cooperation to examine the effects of...
.jpg)
Medical devices are playing a key role in the healthcare ecosystem and provide innovative solutions for improvement of the patient health conditions.
With a target price of Rs 1029.8, ICICI Direct has acquired a call on Sun Pharmaceutical Industries. Sun Pharmaceutical Industries is currently trading at Rs 1010. ICICI Direct advised keeping the stop loss at Rs 1006.3...
Rare diseases are described as potentially fatal or persistently debilitating conditions that affect a limited number of people. Novartis committed around $10 billion on total research and development (R&D) in 2022 and has already received 23...
Lupin Limited (Lupin) announced the opening of a new state-of-the-art Regional Reference Laboratory in Bengaluru, Karnataka, as part of its diagnostics network expansion. The establishment of the new laboratory is a significant step forward in...
care.ai, the first AI-powered Smart Care Facility Platform in healthcare, announced a long-term partnership with Google Cloud, making care.ai's innovative care solutions available on Google Cloud Marketplace. Healthcare organisations and care...
Glenmark Pharmaceuticals Ltd in India is considering selling a majority of its 82% stake in Glenmark Life Sciences Ltd in order to reduce its debt load, according to the Mint business daily on Tuesday. According to two people familiar with the....
Cipla Limited, a pharmaceutical company, has announced that it has signed a perpetual licence agreement with Novartis Pharma AG (Switzerland) to manufacture and market Galvus and Galvus combination brands for the treatment of type 2 diabetes...
, CDSCO.jpg)
